Facial ecthyma gangrenosum in 2 preterm neonates.
M M
MM
Serrano-Martín
J
J
Del Boz
M
M
Chaffanel-Peláez
A
A
Vera-Casaño
D000583:Amikacin / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D017809:Fatal Outcome; D005260:Female; D005734:Gangrene; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D000077731:Meropenem; D009336:Necrosis; D009503:Neutropenia / Q000150:complications; D011552:Pseudomonas Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D018805:Sepsis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D017192:Skin Diseases, Bacterial / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D012883:Skin Ulcer / Q000209:etiology / Q000382:microbiology; D013845:Thienamycins / Q000627:therapeutic use
D013845:Thienamycins; D000583:Amikacin; D000077731:Meropenem